Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan;12(1):48-54.
doi: 10.1038/nrurol.2014.338.

Testosterone therapy and prostate cancer--safety concerns are well founded

Laurence Klotz  1
Affiliations
Review

Testosterone therapy and prostate cancer--safety concerns are well founded

Laurence Klotz. Nat Rev Urol. 2015 Jan.

Abstract

Testosterone is a potent hormone with a variety of physiological effects. The diagnosis of androgen deficiency has increased dramatically over the past decade, along with the widespread use of testosterone supplementation therapy (TST). The long-term effects of TST are uncertain, and the risk of overdiagnosis and overtreatment of men who have a normal age-related decline in testosterone is substantial. The biology of the androgen receptor (AR) pathway is complex, and the saturation model does not take the heterogeneity of human prostate cancer into account. Large-scale trials to confirm the safety of testosterone with respect to the risks of prostate cancer and cardiovascular disease with reasonable confidence limits have not been done, and existing data are insufficient to exclude these adverse events. Instead, evidence suggests that prostate cancer could, in fact, be stimulated by TST, and that the risk of cardiovascular events is increased. Overall, TST seems to impose significant risks, and should be used with caution.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Prog Clin Biol Res. 1988;262:145-60 - PubMed
    1. Diabetes Care. 2011 Apr;34(4):828-37 - PubMed
    1. Int J Sports Med. 2003 Jul;24(5):337-43 - PubMed
    1. J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1451-7 - PubMed
    1. JAMA. 2008 Jan 2;299(1):39-52 - PubMed

MeSH terms